1731
|
|
|
Calcium/calmodulin dependent protein kinase II inhibitor 1 |
PRO1489 |
|
1732
|
|
|
Calcium/calmodulin dependent protein kinase IV |
CaMK IV, CaMK-GR, CaMKIV, caMK |
Alzheimer disease, Asthma, Autoimmune disease, Autoimmune thyroid disease, Colorectal cancer, Neurodevelopmental disorder, Hypothyroidism, Insomnia, Intellectual developmental disorder, Non-specific syndromic intellectual disability, Periodontitis, Severe combined immunodeficiency, Diabetes mellitus type 1, Diabetes mellitus type 2 |
1733
|
|
|
Calcium/calmodulin dependent protein kinase kinase 1 |
CAMKKA |
|
1734
|
|
|
Calcium/calmodulin dependent protein kinase kinase 2 |
CAMKK, CAMKKB |
|
1735
|
|
|
Calmodulin-lysine N-methyltransferase |
C2orf34, CLNMT, CaM KMT, Cam, KMT |
Hypotonia-cystinuria syndrome, Bipolar disorder, Cannabis abuse, Cholecystolithiasis, Developmental coordination disorder, Developmental disability, Essential tremor, Learning disorders, Major depressive disorder, Metabolic syndrome, Mitochondrial myopathy, Motor skills disorder, Obstructive sleep apnea syndrome, Ovarian cancer, Ovarian serous carcinoma, Diabetes mellitus type 2View all (1 more) |
1736
|
|
|
CaM kinase like vesicle associated |
1G5, VACAMKL |
|
1737
|
|
|
Calcium modulating ligand |
CAML, CDG2Z, GET2 |
|
1738
|
|
|
Cathelicidin antimicrobial peptide |
CAP-18, CAP18, CRAMP, FALL-39, FALL39, HSD26, LL37 |
|
1739
|
|
|
Calmodulin regulated spectrin associated protein 1 |
CDCBM12 |
|
1740
|
|
|
Calmodulin regulated spectrin associated protein family member 2 |
CAMSAP1L1 |
|